Kugan Sathiyanandarajah

Kugan Sathiyanandarajah (Menlo Park) joined KKR in 2010 and is a member of the Health Care industry team and Head of KKR’s Health Care Strategic Growth business in Europe.

He was previously a member of KKR’s European Private Equity platform, where he held joint responsibility for the Health Care industry team and has played a significant role in KKR’s investments in LGC Group, Walgreens Boots Alliance, Gamma Biosciences, Alvogen and Galenica. He currently serves on the board of directors of Gamma Biosciences and EchoNous.

Prior to joining KKR, he was with Goldman Sachs, where he was a member of the U.K. mergers and acquisitions team. Mr. Sathiyanandarajah earned an M.A. (First Class Hons) in Physical Natural Sciences (Chemistry) from the University of Cambridge.